UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025215
Receipt number R000029004
Scientific Title Multicenter prospective study of colorectal neuroendocrine tumors
Date of disclosure of the study information 2016/12/10
Last modified on 2020/06/19 10:58:42

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Multicenter prospective study of colorectal neuroendocrine tumors

Acronym

C-NET STUDY

Scientific Title

Multicenter prospective study of colorectal neuroendocrine tumors

Scientific Title:Acronym

C-NET STUDY

Region

Japan


Condition

Condition

Colorectal neuroendocrine tumor (NET)

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the clinicopathological characteristics, diagnosis, treatment, clinical outocomes (recurrence/ metastasis), and prognosis of colorectal neuroendocrine tumors (NETs).

Basic objectives2

Others

Basic objectives -Others

To collect and follow data of colorectal neuroendocrine tumors (NETs) from multiple centers.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Recurrence and metastasis

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Maneuver

Interventions/Control_1

Colonoscopy and abdominal computed tomography 1, 5 and 10 years after registration

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

74 years-old >=

Gender

Male and Female

Key inclusion criteria

Patients aged between 20 and 74 years with pathologically confirmed colorectal neuroendocrine tumors

Key exclusion criteria

1. Cases in which it is difficult to get informed consent
2. Cases which are considered as inappropriate by doctors

Target sample size

800


Research contact person

Name of lead principal investigator

1st name Takahisa
Middle name
Last name Matsuda

Organization

National Cancer Center Hospital

Division name

Cancer Screening Center/ Endoscopy Division

Zip code

1040045

Address

5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan

TEL

+81-3-3542-2511

Email

tamatsud@ncc.go.jp


Public contact

Name of contact person

1st name Masau
Middle name
Last name Sekiguchi

Organization

National Cancer Center Hospital

Division name

Cancer Screening Center/ Endoscopy Division

Zip code

1040045

Address

5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan

TEL

+81-3-3542-2511

Homepage URL


Email

masekigu@ncc.go.jp


Sponsor or person

Institute

National Cancer Center Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Cancer Center

Address

5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan

Tel

+81-3-3542-2511

Email

irst@ml.res.ncc.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立がん研究センター中央病院(東京都)、広島大学(広島県)、東邦大学医療センター大橋病院(東京都)、石川県立中央病院(石川県)、佐野病院(兵庫県)、国立がん研究センター東病院(千葉県)、愛知県がんセンター中央病院(愛知県)、NTT東日本札幌病院(北海道)、北摂総合病院(大阪府)、宝塚市立病院(兵庫県)、大阪府立成人病センター(大阪府)、広島市立安佐市民病院(広島県)、斗南病院(北海道)、京都桂病院(京都府)、近畿大学(大阪府)、秋田赤十字病院(秋田県)、金沢医科大学(石川県)、四国がんセンター(愛媛県)、東京慈恵会医科大学(東京都)、静岡県立静岡がんセンター(静岡県)、JCHO大阪病院(大阪府)、NTT東日本関東病院(東京都)、赤坂内視鏡クリニック(東京都)、旭川医科大学(北海道)、岩手医科大学(岩手県)、岩手県立胆沢病院(岩手県)、大阪市立大学附属病院(大阪府)、大阪大学(大阪府)、岡山大学病院(岡山県)、尾田胃腸内科(熊本県)、香川大学医学部附属病院(香川県)、がん・感染症センター都立駒込病院(東京都)、がん研有明病院(東京都)、関西医科大学(大阪府)、北里大学病院(神奈川県)、九州大学(福岡県)、京都医療センター(京都府)、京都大学(京都府)、京都府立医科大学(京都府)、久留米大学消化器病センター(福岡県)、群馬中央病院(群馬県)、済生会吹田病院(大阪府)、堺市立総合医療センター(大阪府)、札幌医科大学医学部附属病院(北海道)、自治医科大学附属病院(栃木県)、市立旭川病院(北海道)、高槻赤十字病院(大阪府)、筑波大学附属病院(茨城県)、東京医科大学病院(東京都)、東京医療センター(東京都)、東京女子医科大学(東京都)、東京女子医大東医療センター(東京都)、東京大学(東京都)、徳島大学(徳島県)、栃木県立がんセンター(栃木県)、戸畑共立病院(福岡県)、新潟大学医歯学総合病院(新潟県)、兵庫医科大学(兵庫県)、広島市民病院(広島県)、弘前大学(青森県)、福岡大学筑紫病院(福岡県)、三重大学(三重県)、石川消化器内科(大阪府)


Other administrative information

Date of disclosure of the study information

2016 Year 12 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

502

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 10 Month 05 Day

Date of IRB

2016 Year 10 Month 27 Day

Anticipated trial start date

2017 Year 01 Month 12 Day

Last follow-up date

2029 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 12 Month 10 Day

Last modified on

2020 Year 06 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029004


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2022/04/04 20210121 大腸NET Studyデータ固定用_update_20220317.xlsx